Equities
Health CareHealth Care Equipment & Services
  • Price (GBX)1,451.00
  • Today's Change-9.50 / -0.65%
  • Shares traded2.83m
  • 1 Year change13.98%
  • Beta0.5034
Data delayed at least 20 minutes, as of Feb 15 2019 17:04 GMT.
More ▼

Key statistics

On Friday, Smith & Nephew PLC (SN.:LSE) closed at 1,451.00, -6.30% below its 52-week high of 1,548.50, set on Dec 10, 2018.
52-week range
Today
1,242.50Oct 26 20181,548.50Dec 10 2018
Markit short selling activity
Low
Med
High
Open1,463.50
High1,464.00
Low1,444.50
Bid--
Offer--
Previous close1,460.50
Average volume3.05m
Shares outstanding875.23m
Free float871.44m
P/E (TTM)24.54
Market cap12.70bn GBP
EPS (TTM)0.5912
GBP
Annual div (ADY)34.13
GBX
Annual div yield (ADY)2.37%
Div ex-dateOct 04 2018
Div pay-dateOct 31 2018
Next div ex-dateApr 04 2019
Next div pay-dateMay 08 2019
Data delayed at least 20 minutes, as of Feb 15 2019 17:04 GMT.
More ▼

Investors Chronicle View

The last IC recommendation on Smith & Nephew PLC shares was Buy at 1,464.00 on 14 Feb 2019Read the full article
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.